The Latest Cardiac and Vascular News
CLICHY, France–(BUSINESS WIRE)–The medtech company CorWave is taking a new step in its development. Already located in Clichy, next to Paris, the industrial start-up is preparing to move to larger premises capable of hosting its R&D center and the manufacturing facility needed to enter the clinical and commercial phases. The […]
Que Dallara joins as EVP & President, Diabetes Mike Marinaro named President, Surgical Robotics Dr. Kweli Thompson named President, Cardiac Rhythm Management DUBLIN, March 17, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced leadership transitions for three of its Operating Units – Diabetes, Surgical Robotics, and Cardiac Rhythm Management – […]
PLANO, Texas, March 17, 2022 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource (MDO) manufacturer, announced today that Bill R. Sanford will be retiring as Chair of the Integer Board of Directors at the conclusion of the Company’s 2022 annual meeting of stockholders, which is scheduled […]
– Received tentative FDA approval of YUTREPIA™ (treprostinil) inhalation powder – Expanded use of Treprostinil Injection to include subcutaneous administration – Preparing to launch YUTREPIA in late-2022 pending final FDA approval – Company to host webcast and conference call today at 8:30 a.m. ET MORRISVILLE, N.C., March 17, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation […]
BOSTON, March 17, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (NASDAQ: CINC), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases, today announced that the Company will be added to the Russell 2000® and Russell 3000® Indexes, effective on Friday, […]
Seasoned electrophysiology commercial leader joins the Company to expand operating capabilities Westport, CT, March 16, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG […]
Deployment of a Novel 4-Minute City Program that Engages Community Members to Speed AED Response Time, Improve Survival Rates and Focus on Overcoming Socioeconomic Disparities in Healthcare SAN FRANCISCO, March 16, 2022 /PRNewswire/ — Avive Solutions, Inc., developer of an intelligent AED and connected response platform for out-of-hospital cardiac arrest (OHCA) emergencies, today […]
Investment to drive future growth and innovation and strengthen market leadership position CALGARY, AB and SAN FRANCISCO, March 16, 2022 /PRNewswire/ — Circle Cardiovascular Imaging Inc. (“Circle CVI”), the global leader in cardiovascular imaging solutions, today announced a strategic growth investment from Thoma Bravo, a leading software investment firm. Thoma Bravo’s partnership is expected […]
Added 4 additional innovative product candidates Strong growth in H2 leading to total revenues of €3.1 million (€0.2 million in 2020) Significant expansion of commercial footprint of Maxigesic® IV Tranexamic RTU licensing extended beyond U.S. €50 million in cash and cash equivalents to execute ambitious growth strategy LIÈGE, Belgium, March […]
PHILADELPHIA, March 15, 2022 /PRNewswire/ — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to developing best-in-class, novel therapy for the treatment of hypertension, today announced the appointment of Adam Levy as the company’s new Chief Financial Officer (CFO) and Chief Business Officer (CBO). “We are pleased to announce Adam’s appointment and welcome […]
